A Look At PACS Group (PACS) Valuation After Record Earnings And Zacks Rank Upgrade

Simply Wall St.03-14

PACS Group (PACS) stock has been in focus after management used the latest earnings call to outline record revenue, firmer margins, and a 2026 outlook that points to higher revenue and EBITDA. See our...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2619128307?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","is_english":true,"pubTime":"2026-03-14 14:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619128307","market":"sg","top_or_hot":-1,"title":"A Look At PACS Group (PACS) Valuation After Record Earnings And Zacks Rank Upgrade","media":"Simply Wall St.","content":"<div>\n<p>PACS Group (PACS) stock has been in focus after management used the latest earnings call to outline record revenue, firmer margins, and a 2026 outlook that points to higher revenue and EBITDA. See our...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/a-look-at-pacs-group-pacs-valuation-after-record-earnings-an\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At PACS Group (PACS) Valuation After Record Earnings And Zacks Rank Upgrade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At PACS Group (PACS) Valuation After Record Earnings And Zacks Rank Upgrade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-14 14:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/a-look-at-pacs-group-pacs-valuation-after-record-earnings-an><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PACS Group (PACS) stock has been in focus after management used the latest earnings call to outline record revenue, firmer margins, and a 2026 outlook that points to higher revenue and EBITDA. See our...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/a-look-at-pacs-group-pacs-valuation-after-record-earnings-an\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PACS","symbol_name":"PACS Group","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/a-look-at-pacs-group-pacs-valuation-after-record-earnings-an","article_id":"2619128307","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/a-look-at-pacs-group-pacs-valuation-after-record-earnings-an","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2619128307","pubTimestamp":1773469688,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"PACS Group (PACS) stock has been in focus after management used the latest earnings call to outline record revenue, firmer margins, and a 2026 outlook that points to higher revenue and EBITDA.\nSee our latest analysis for PACS Group.\nAt a share price of US$34.84, PACS Group has seen a 3.41% 1 day share price return and a 1.63% 7 day share price return. However, the 30 day share price return shows an 11.08% decline, which contrasts with a 1 year total shareholder return of 195%. This suggests...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["rate","earning"],"viewcount":null,"language":"en","relate_stocks":{"PACS":"PACS Group"},"translate_title":"创纪录收益和Zacks排名升级后PACS Group(PACS)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PACS":1.5},"content_text":"PACS Group (PACS) stock has been in focus after management used the latest earnings call to outline record revenue, firmer margins, and a 2026 outlook that points to higher revenue and EBITDA. See our latest analysis for PACS Group. At a share price of US$34.84, PACS Group has seen a 3.41% 1 day share price return and a 1.63% 7 day share price return. However, the 30 day share price return shows an 11.08% decline, which contrasts with a 1 year total shareholder return of 195%. This suggests that recent momentum has cooled after a powerful run as investors digest the earnings call, acquisitions, the appointment of Dr. Patrick Conway to the board, and the Zacks Rank #1 upgrade. If PACS Group’s recent moves have caught your eye, this can be a good moment to broaden your watchlist and check out 33 healthcare AI stocks identified by our screener as potential healthcare opportunities linked to AI trends. With record revenue, firmer margins, and a 2026 guide that points to higher revenue and EBITDA already on the table, the question now is simple: is PACS Group still mispriced, or is the market already baking in that growth? AdvertisementMost Popular Narrative: 50% Undervalued At a last close of $34.84 compared to a narrative fair value of $35.00, the headline gap looks tiny, but the underlying model still tags PACS Group as 50% undervalued once all assumptions are discounted back at 7.2%.  Systematic improvement of newly acquired and turnaround facilities from low single digit margins toward the high single digit and low double digit margin profile of mature sites should unlock embedded profitability, lifting consolidated net margins and EBITDA over time.  Read the complete narrative. Read the complete narrative. The story behind that fair value hinges on how quickly earnings, margins and the facility portfolio mix shift over the next few years. One core assumption about profit growth sits at the heart of the model, and it is tied directly to how analysts see PACS Group scaling its current footprint. If you want to see exactly which revenue and earnings paths have been baked in, the full narrative lays out those numbers in detail. Result: Fair Value of $35 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this depends on successfully integrating more than 100 newly acquired facilities and maintaining stable Medicaid and quality incentive frameworks in key states such as California and Texas. Find out about the key risks to this PACS Group narrative. Another View: Rich On Earnings Multiples That 50% undervalued narrative sits awkwardly next to the P/E math. At a 28.6x P/E, PACS trades well above the US Healthcare industry at 22.1x, its peer average at 22.8x, and a fair ratio of 20.7x, which points to valuation risk rather than a clear bargain. So which story do you trust more: the growth model or the current price tag? See what the numbers say about this price — find out in our valuation breakdown. NYSE:PACS P/E Ratio as at Mar 2026Next Steps If this mix of optimism and valuation questions has you thinking hard about PACS Group, it is worth checking the numbers yourself and moving quickly to shape your own view, especially given the positive factors already on investors’ radar, and you can weigh those for yourself by taking a closer look at 3 key rewards. Looking for more investment ideas? If PACS Group is already on your radar, do not stop there. Widen your opportunity set with focused stock lists built from clear, transparent fundamentals.  Spot potential bargains early by checking our list of screener containing 26 high quality undiscovered gems that combine solid business quality with less crowded attention. Strengthen your downside protection by reviewing 68 resilient stocks with low risk scores, highlighting companies with lower overall risk scores based on their fundamentals. Target resilient balance sheets by scanning solid balance sheet and fundamentals stocks screener (42 results), featuring businesses screened for financial strength and core stability.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2619128307","isCrawlerRequest":true}